Analyst Consensus ?
ConsensusBuy29 ratings
Bullish2275.9%
Neutral724.1%
Bearish00.0%
GE Vernova Inc. · GEV · FY2025 Q2 · Calendar Q3 2025
GE Vernova raises guidance as Power and Electrification lead Q2
The supplied analysis supports a constructive but qualified outlook: strong Power and Electrification demand, backlog growth, and raised guidance provide evidence for continued earnings momentum, while Wind losses, pricing softness, tariffs, and restructuring costs are material counterweights.
Reported Before market openNYSEIndustrials
$252.96B market cap
90quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.86
Consensus $1.48
EPS surprise
+25.7%
Reported versus consensus
Reported revenue
$9.11B
Consensus $8.81B
Revenue surprise
+3.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+14.6%
Event window
SPY move
+0.9%
Same window
Abnormal move
+13.7%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
-3.9%
Up to 20 sessions
GEVSPY benchmark
Ask FN2 about GEV FY2025 Q2
Transcript, numbers and history already loaded
Why did GEV rise 14.6% after beating EPS estimates in FY2025 Q2?What changed in GEV's guidance and outlook in FY2025 Q2?Give me the bull and bear case for GEV after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter added evidence of demand strength in Power and Electrification, included raised full-year guidance, and highlighted strategic moves in AI-enabled grid software, SMR development, automation, and targeted acquisitions.
Guidance delta
Management raised full-year 2025 revenue, EBITDA-margin, and free-cash-flow guidance, with revenue at the high end of its $36–$37 billion range.
Key takeaways
- The supplied analysis describes Q2 revenue growth and EBITDA expansion led by Power and Electrification.
- Demand indicators included gas turbines, grid equipment, synchronous condensers, and data-center power needs.
- Wind remained loss-making, although onshore improvement and offshore production progress were cited.
- The company’s backlog and planned investments support the growth case, while pricing, tariffs, and restructuring remain key watch items.
Management priorities
- Expand gas-power, grid-modernization, and synchronous-condenser capacity.
- Advance SMR deployment and integrate AI visualization into GridOS.
- Invest in automation, factory capacity, strategic acquisitions, and share buybacks.
Follow GEV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$949.77Current
$160Low
$843.97Average
$1,450High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Sep 15, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 27, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 11, 2026 |
| BNP Paribas | Neutral | Outperform | Downgrade | Apr 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 23, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 13, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 9, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 31, 2026 |
| Rothschild & Co | Buy | Sell | Upgrade | Mar 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 29, 2026 |
| GLJ Research | Buy | Buy | Maintain | Jan 12, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Dec 11, 2025 |
| UBS | Buy | Buy | Maintain | Dec 10, 2025 |
| B of A Securities | Buy | Buy | Maintain | Dec 10, 2025 |
| Melius Research | Buy | Hold | Upgrade | Sep 15, 2025 |
| HSBC | Hold | Hold | Maintain | Sep 5, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 23, 2025 |
| Daiwa Capital | Buy | Outperform | Maintain | Oct 30, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 2, 2024 |
Named analyst price targets
Upside is calculated against the persisted current price $949.77. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Analyst unavailable | $1,185 | $953.2 | +24.8% | Sep 11, 2026 |
| Mizuho Securities | Maheep Mandloi | $949 | $1,020.52 | -0.1% | Jul 24, 2026 |
| RBC Capital | Analyst unavailable | $1,225 | $1,002.04 | +29.0% | Jul 23, 2026 |
| Oppenheimer | Analyst unavailable | $1,338 | $1,020.58 | +40.9% | Jul 23, 2026 |
| Guggenheim | Joseph Osha | $1,450 | $985.03 | +52.7% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,298 | $985.03 | +36.7% | Jul 23, 2026 |
| Bernstein | Sunaina Ocalan | $1,206 | $982.35 | +27.0% | Jun 16, 2026 |
| Bernstein | Sunaina Ocalan | $1,208 | $982.35 | +27.2% | Jun 16, 2026 |
| Jefferies | Julian Dumoulin-Smith | $1,210 | $901.02 | +27.4% | Jun 11, 2026 |
| Argus Research | John Eade | $1,300 | $1,107 | +36.9% | Apr 27, 2026 |
| BNP Paribas | Analyst unavailable | $1,190 | $1,149.19 | +25.3% | Apr 27, 2026 |
| Goldman Sachs | Analyst unavailable | $1,328 | $1,149.53 | +39.8% | Apr 24, 2026 |
| Jefferies | Julien Dumoulin-Smith | $1,350 | $1,149.53 | +42.1% | Apr 24, 2026 |
| Oppenheimer | Analyst unavailable | $1,303 | $1,150.74 | +37.2% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $1,195 | $1,153.57 | +25.8% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $1,250 | $1,127.56 | +31.6% | Apr 23, 2026 |
| Susquehanna | Analyst unavailable | $1,300 | $1,127.56 | +36.9% | Apr 23, 2026 |
| Guggenheim | Joseph Osha | $1,300 | $1,127.56 | +36.9% | Apr 23, 2026 |
| Robert W. Baird | Ben Kallo | $1,400 | $1,127.56 | +47.4% | Apr 23, 2026 |
| Barclays | Julian Mitchell | $1,250 | $1,127.56 | +31.6% | Apr 23, 2026 |
| Oppenheimer | Colin Rusch | $1,139 | $982.74 | +19.9% | Apr 16, 2026 |
| Susquehanna | Charles Minervino | $1,080 | $968.02 | +13.7% | Apr 9, 2026 |
| Redburn Partners | Analyst unavailable | $1,100 | $830.1 | +15.8% | Mar 9, 2026 |
| Robert W. Baird | Ben Kallo | $923 | $780.25 | -2.8% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $714 | $754.97 | -24.8% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $849 | $726.37 | -10.6% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $800 | $717.39 | -15.8% | Jan 30, 2026 |
| Guggenheim | Analyst unavailable | $910 | $717.39 | -4.2% | Jan 30, 2026 |
| UBS | Analyst unavailable | $936 | $694.64 | -1.4% | Jan 29, 2026 |
| UBS | Analyst unavailable | $871 | $708.31 | -8.3% | Jan 29, 2026 |
| Evercore ISI | Alexander Virgo | $905 | $707.73 | -4.7% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $701 | $711.59 | -26.2% | Jan 29, 2026 |
| BMO Capital | Analyst unavailable | $785 | $711.59 | -17.3% | Jan 29, 2026 |
| Susquehanna | Analyst unavailable | $820 | $711.59 | -13.7% | Jan 29, 2026 |
| Jefferies | Julian Dumoulin-Smith | $930 | $688.5 | -2.1% | Jan 29, 2026 |
| Goldman Sachs | Analyst unavailable | $925 | $711.59 | -2.6% | Jan 29, 2026 |
| Morgan Stanley | David Arcaro | $817 | $657.78 | -14.0% | Jan 26, 2026 |
| GLJ Research | Austin Wang | $1,087 | $622.5 | +14.4% | Jan 12, 2026 |
| Robert W. Baird | Ben Kallo | $649 | $628.4 | -31.7% | Jan 9, 2026 |
| Barclays | Analyst unavailable | $830 | $686.33 | -12.6% | Jan 7, 2026 |
| Jefferies | Julien Dumoulin-Smith | $830 | $658.28 | -12.6% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $816 | $650.82 | -14.1% | Dec 18, 2025 |
| Jefferies | Analyst unavailable | $815 | $614.19 | -14.2% | Dec 18, 2025 |
| Goldman Sachs | Joe Ritchie | $840 | $681.35 | -11.6% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $822 | $681.35 | -13.5% | Dec 16, 2025 |
| Wells Fargo | Michael Blum | $831 | $681.35 | -12.5% | Dec 16, 2025 |
| Evercore ISI | Alexander Virgo | $860 | $672.56 | -9.5% | Dec 15, 2025 |
| Seaport Global | Tom Curran | $723 | $690.15 | -23.9% | Dec 11, 2025 |
| UBS | Amit Mehrotra | $835 | $713.78 | -12.1% | Dec 10, 2025 |
| Susquehanna | Charles Minervino | $775 | $625.3 | -18.4% | Dec 10, 2025 |
| BMO Capital | Ameet Thakkar | $780 | $625.3 | -17.9% | Dec 10, 2025 |
| RBC Capital | Christopher Dendrinos | $761 | $625.3 | -19.9% | Dec 10, 2025 |
| Oppenheimer | Colin Rusch | $855 | $625.3 | -10.0% | Dec 10, 2025 |
| Barclays | Julian Mitchell | $720 | $601.97 | -24.2% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $710 | $577.97 | -25.2% | Oct 30, 2025 |
| Jefferies | Julian Dumoulin-Smith | $654 | $585.34 | -31.1% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $660 | $609.65 | -30.5% | Oct 24, 2025 |
| RBC Capital | Christopher Dendrinos | $630 | $586.85 | -33.7% | Oct 23, 2025 |
| BMO Capital | Analyst unavailable | $710 | $576 | -25.2% | Oct 23, 2025 |
| Susquehanna | Analyst unavailable | $750 | $576 | -21.0% | Oct 23, 2025 |
| UBS | Analyst unavailable | $710 | $592.21 | -25.2% | Oct 23, 2025 |
| Morgan Stanley | Analyst unavailable | $690 | $615.95 | -27.4% | Oct 16, 2025 |
| GLJ Research | Analyst unavailable | $758 | $658.98 | -20.2% | Oct 15, 2025 |
| Mizuho Securities | Maheep Mandloi | $677 | $644.41 | -28.7% | Oct 15, 2025 |
| Redburn Partners | Analyst unavailable | $475 | $644.41 | -50.0% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $740 | $628.36 | -22.1% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $605 | $614.9 | -36.3% | Oct 1, 2025 |
| Melius Research | Analyst unavailable | $740 | $625.55 | -22.1% | Sep 15, 2025 |
| Seaport Global | Tom Curran | $630 | $540.07 | -33.7% | Jul 10, 2025 |
| UBS | Amit Mehrotra | $614 | $517.04 | -35.4% | Jul 7, 2025 |
| Susquehanna | Charles Minervino | $370 | $330.8 | -61.0% | Apr 2, 2025 |
| Truist Financial | Analyst unavailable | $440 | $303 | -53.7% | Mar 27, 2025 |
| RBC Capital | Analyst unavailable | $445 | $317.06 | -53.1% | Mar 18, 2025 |
| New Street | Analyst unavailable | $380 | $316.8 | -60.0% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $380 | $316.8 | -60.0% | Mar 5, 2025 |
| BMO Capital | Analyst unavailable | $420 | $315.98 | -55.8% | Mar 3, 2025 |
| Guggenheim | Joseph Osha | $400 | $351.46 | -57.9% | Dec 5, 2024 |
| Mizuho Securities | Maheep Mandloi | $351 | $343.57 | -63.0% | Dec 2, 2024 |
| J.P. Morgan | Mark Strouse | $330 | $295.9 | -65.3% | Oct 24, 2024 |
| RBC Capital | Christopher Dendrinos | $285 | $279.88 | -70.0% | Oct 24, 2024 |
| Goldman Sachs | Joe Ritchie | $324 | $279.88 | -65.9% | Oct 24, 2024 |
| Jefferies | Andrew Tsai | $165 | $274.85 | -82.6% | Oct 21, 2024 |
| Deutsche Bank | Nicole DeBlase | $354 | $272.72 | -62.7% | Oct 21, 2024 |
| RBC Capital | Christopher Dendrinos | $262 | $272 | -72.4% | Oct 18, 2024 |
| Jefferies | Julian Dumoulin-Smith | $336 | $272 | -64.6% | Oct 17, 2024 |
| HSBC | Sean McLoughlin | $255 | $261.61 | -73.2% | Oct 4, 2024 |
| Truist Financial | Jordan Levy | $300 | $255.05 | -68.4% | Sep 26, 2024 |
| Jefferies | Julien Dumoulin-Smith | $293 | $247.39 | -69.2% | Sep 20, 2024 |
| Bank of America Securities | Andrew Obin | $300 | $229.93 | -68.4% | Sep 17, 2024 |
| Mizuho Securities | Maheep Mandloi | $241 | $225.59 | -74.6% | Sep 16, 2024 |
| Barclays | Julian Mitchell | $250 | $225.59 | -73.7% | Sep 16, 2024 |
| Morgan Stanley | Andrew Percoco | $256 | $215.27 | -73.0% | Sep 13, 2024 |
| BMO Capital | Ameet Thakkar | $245 | $215.27 | -74.2% | Sep 13, 2024 |
| Goldman Sachs | Joe Ritchie | $220 | $214.58 | -76.8% | Sep 12, 2024 |
| Jefferies | Julien Dumoulin-Smith | $261 | $192.55 | -72.5% | Sep 3, 2024 |
| HSBC | Sean McLoughlin | $215 | $178.24 | -77.4% | Aug 12, 2024 |
| Morgan Stanley | Andrew Percoco | $220 | $174.03 | -76.8% | Aug 1, 2024 |
| Mizuho Securities | Maheep Mandloi | $208 | $160 | -78.1% | Jul 26, 2024 |
| Daiwa | Dennis Ip | $201.5 | $177.18 | -78.8% | Jun 21, 2024 |
| Argus Research | John Eade | $190 | $177.52 | -80.0% | Jun 13, 2024 |
| RBC Capital | Christopher Dendrinos | $180 | $177.32 | -81.0% | May 30, 2024 |
| Morgan Stanley | Andrew Percoco | $167 | $163.85 | -82.4% | May 23, 2024 |
| Mizuho Securities | Maheep Mandloi | $164 | $151.91 | -82.7% | May 1, 2024 |
| Evercore ISI | James West | $174 | $134.75 | -81.7% | Apr 17, 2024 |
| Raymond James | Patel Molchanov | $160 | $130.07 | -83.2% | Apr 16, 2024 |
| Goldman Sachs | Joe Ritchie | $154 | $131.75 | -83.8% | Apr 16, 2024 |
| Mizuho Securities | Maheep Mandloi | $154 | $134 | -83.8% | Apr 15, 2024 |
| RBC Capital | Christopher Dendrinos | $160 | $140 | -83.2% | Apr 1, 2024 |
Track every rating change on GEV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationGE Vernova Inc. is an energy enterprise primarily engaged in generating electricity. Its business activities are categorized into three main divisions: Power, Wind, and Electrification. The Power segment is responsible for producing and distributing electricity from various sources, including hydroelectric, natural gas, nuclear, and steam power. The Wind division concentrates on the fabrication and sale of wind turbine blades. Meanwhile, the Electrification segment offers an array of services such as grid infrastructure solutions, power conversion technologies, and both solar and energy storage systems. The company was established in 2023 and has its headquarters situated in Cambridge, Massachusetts.
Historical context
All GEV earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the GEV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-09-29T04:06:13.437053+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T04:06:13.434316+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.